An Exploratory, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Efficacy of Arbaclofen in Subjects with 16p11.2 deletion (Subaward) Grant uri icon

Overview

date/time interval

  • July 1, 2024 - June 30, 2025

sponsor award ID

  • RFMH 251486-01

Affiliation